Markets › LSE › 0QCV.L

AbbVie Inc.

LSE:0QCV.LHealthcare

——At close · Market cap — · Next earnings Thu 29 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	66.7%	69.2%	71.5%	69.2%	70.4%	71.6%	—	—
Operating margin	24.8%	31.9%	31.2%	23.5%	16.2%	24.6%	24.6%	+0.0 pts
Net margin	9.9%	20.4%	20.3%	8.9%	7.6%	6.9%	6.9%	+0.0 pts
EBITDA margin	46.2%	50.3%	54.1%	48.5%	47.4%	47.8%	—	—
Return on equity	34.8%	74.4%	68.3%	46.5%	128.7%	−129.2%	−130.9%	−1.7 pts
Return on assets	3.0%	7.8%	8.5%	3.6%	3.2%	3.2%	3.2%	+0.0 pts
Return on capital employed	9.3%	16.1%	16.6%	13.2%	9.5%	16.6%	—	—
Debt / equity	6.6×	5.0×	3.7×	5.8×	20.5×	−20.9×	−21.2×	−1.3%
Debt / assets	57.7%	52.8%	46.4%	44.8%	50.3%	51.1%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	4.2×	0.0×	—	—
Current ratio	0.8×	0.8×	1.0×	0.9×	0.7×	0.7×	0.7×	+0.0%
Quick ratio	0.7×	0.7×	0.8×	0.8×	0.6×	0.6×	—	—
Cash ratio	0.3×	0.3×	0.3×	0.3×	0.1×	0.1×	0.1×	+0.0%
Asset turnover	0.3×	0.4×	0.4×	0.4×	0.4×	0.5×	—	—
Inventory turnover	4.6×	5.5×	4.6×	4.1×	4.0×	3.5×	—	—
Receivables turnover	5.2×	5.6×	5.2×	4.9×	5.2×	4.9×	—	—
Dividend payout	169.4%	80.8%	85.2%	218.7%	257.7%	275.8%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.